Loading institutional data...
Loading institutional data...
Institutional distribution: ownership decreased -1.38% quarter-over-quarter.
Data as of Q1 2026
Loading snapshot...
Loading financials...
Loading valuation...
Loading quality & risk...
Loading dividends & returns...
Loading capital allocation...
Loading debt & leverage...
Loading performance...
Loading peer comparison...
Loading ownership map...
Loading crowding analysis...
Loading conviction analysis...
Loading buy/sell flow...
Loading ownership trends...
Loading top holders...
Loading top holders...
Solve the discounted cash flow backwards, then stress-test the assumptions.
To be worth $0.71 today, the market must believe free cash flow compounds -16.5%/yr for a decade (off $23M normalized FCF).
The market's -16.5% is more conservative than its 2-yr track record.
2-stage DCF · 0.13B shares · net debt $0
mean 63.8% · volatility σ 110% · implied rate exceeded in 2/2 yrs
Central path = implied -16.5%/yr growth; shaded band = ±1σ (110%) of this company's historical FCF volatility, widening with time. The wider the band, the less certain the growth.
Reverse DCF: rather than guessing a fair value, we solve for the growth the current price implies, then you stress-test the assumptions. Enterprise value of the FCF stream, less net debt, ÷ shares. Educational — not a recommendation.
Total shares institutions bought (green) vs sold (red) each quarter across all holders.
Inferred from quarter-over-quarter change in each fund's 13F position (new stakes count as buys, exits as sells). Not tick-level trades.
Total return (dividends reinvested) vs the market, from quarter-end prices.
Above 0 = ahead of the S&P 500 since the window start; below 0 = behind. Rising means it's pulling ahead.
How far the stock fell below its prior peak. Deeper, longer drawdowns = a rougher ride to the same return.
Quarter-end, dividend-adjusted (total return). Beta & volatility from quarterly returns (annualized). Benchmark is the S&P 500 (SPY total return). Annual returns compound the quarters ending in each calendar year; the first and last years in a window may be partial. Past performance doesn't predict future results.
EOD close · as of 2026-08-05 · 15d old
How a revenue dollar becomes profit — FY2025
Each value shows its share of revenue below it (common-size).
| Line Item | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 |
|---|---|---|---|---|---|---|---|
| Revenue | $300.8M 100.0% | $334.3M 100.0% | $398.0M 100.0% | $365.9M 100.0% | $260.1M 100.0% | $119.1M 100.0% | $166.6M 100.0% |
| Cost of Revenue | $104.4M 34.7% | $152.0M 45.5% | $242.9M 61.0% | $117.1M 32.0% | $81.5M 31.4% | $51.9M 43.6% | $60.1M 36.1% |
| Gross Profit | $196.4M 65.3% | $182.3M 54.5% | $155.1M 39.0% | $248.8M 68.0% | $178.5M 68.6% | $67.2M 56.4% | $106.5M 63.9% |
| Research & Development | $5.6M 1.9% | $6.3M 1.9% | $10.1M 2.5% | $8.4M 2.3% | $8.2M 3.2% | $3.4M 2.9% | $4.6M 2.8% |
| Selling, General & Admin | $117.9M 39.2% | $125.5M 37.5% | $131.4M 33.0% | $106.1M 29.0% | $98.7M 37.9% | $30.6M 25.7% | $26.7M 16.0% |
| Total Operating Expenses | $217.2M 72.2% | $250.1M 74.8% | $286.0M 71.9% | $274.6M 75.1% | $218.5M 84.0% | $84.4M 70.9% | $93.0M 55.8% |
| Operating Income | -$20.8M -6.9% | -$67.8M -20.3% | -$130.9M -32.9% | -$25.8M -7.1% | -$39.9M -15.4% | -$17.2M -14.4% | $13.5M 8.1% |
| Interest Expense | $19.3M 6.4% | $10.4M 3.1% | $13.6M 3.4% | $13.4M 3.7% | $11.8M 4.5% | — | — |
| Interest & Investment Income | $9.0M 3.0% | $16.6M 5.0% | $23.2M 5.8% | $9.2M 2.5% | $39K 0.0% | $0 0.0% | — |
| Other Income (Expense), net | $18.9M 6.3% | $33.6M 10.0% | $5.2M 1.3% | -$1.6M -0.5% | -$340.7M -131.0% | -$21.3M -17.9% | -$16.4M -9.8% |
| Pretax Income | -$5.9M -2.0% | -$29.6M -8.8% | -$101.9M -25.6% | $45.3M 12.4% | -$380.6M -146.4% | -$38.5M -32.3% | -$2.9M -1.8% |
| Income Tax Expense | $3.6M 1.2% | -$452K -0.1% | -$1.8M -0.4% | $1.1M 0.3% | -$1.9M -0.7% | -$9.3M -7.8% | -$1.3M -0.8% |
| Net Income | -$9.5M -3.2% | -$29.1M -8.7% | -$100.1M -25.2% | $44.2M 12.1% | $378.7M 145.6% | -$29.2M -24.5% | -$1.6M -1.0% |
| Per Share | |||||||
| EPS (Basic) | $-0.08 | $-0.23 | $-0.76 | $0.30 | $-3.71 | $-0.85 | $-0.05 |
| EPS (Diluted) | $-0.16 | $-0.36 | $-0.76 | $-0.23 | $-3.71 | $-0.85 | $-0.05 |
| Weighted Avg Shares (Basic) | 126.4M | 123.8M | 131.7M | 147.6M | 102.1M | 34.3M | 32.1M |
| Weighted Avg Shares (Diluted) | 135.8M | 142.5M | 131.7M | 148.5M | 102.1M | 34.3M | 32.1M |
Source: SEC EDGAR XBRL filings (annual, fiscal year). Quarterly flow items are derived from cumulative filings; balance-sheet figures are as-of each period end. Ratios and margins are computed, not reported.
Is the value real, and is the business safe? Academic scores + earnings quality + solvency, from SEC filings.
5/8 of the 9 checks — 1 couldn't be scored (see above), so the score is out of the 8 with data.
Safe > 2.99 · grey 1.81–2.99 · distress < 1.81
Needs granular two-year detail (receivables, PP&E, D&A, SG&A) — not fully reported.
Cash-conversion data unavailable. Lower/negative accruals = higher quality (Sloan).
Interest coverage is thin — monitor.
F-Score (0–9 fundamental momentum), Altman Z (distress risk), and Beneish M (earnings-manipulation screen) are academic models computed from the SEC filings. Screens and context — educational, not recommendations.
What the company returns to shareholders — and whether it's covered by cash.
No dividend to cover. Last year: $0 dividends + $0 buybacks = $0 returned on $37M FCF.
Yields use the latest fiscal-year dividends/buybacks over current market cap. Dividends and buybacks from the SEC cash-flow statement; payout coverage vs net income and free cash flow. Educational — not a recommendation.
How management deployed cash over 7 years — and what it earned on reinvestment.
A cash-return story — far more went to shareholders than back into the business (mature, low-reinvestment).
Operating income fell despite reinvestment — a warning on capital productivity. Current ROIC on all capital: -16%. Rough measure (includes maintenance capex).
Cash uses aggregated from the SEC cash-flow statement over 7 fiscal years. "Return on reinvestment" is a rough proxy — operating-income change ÷ cumulative CapEx + M&A — and includes maintenance capex. Educational — not a recommendation.
How much the company owes, how it's trended, and how comfortably it's serviced.
Insufficient EBITDA/debt history.
Green ≤ 1.5× · amber ≤ 3× · red > 3× (leverage relative to cash earnings).
Thin coverage — earnings barely cover interest.
Cash vs short-term debt unavailable.
Short-term / long-term split not separately reported.
Debt, cash, interest and equity from the SEC balance sheet & income statement. Effective rate = interest ÷ average debt. Educational — not a recommendation.
EOD close · as of 2026-08-05
Where each multiple sits in its own 6-yr range · 0th pct blended
Dot = today · shaded = middle 50% · line = median. Lower percentile = cheaper vs its own 6-yr history.
Is the profit real, and how strong is the balance sheet?
FY2025 · every deduction from revenue to net income
DuPont — the three levers
Watch the leverage lever — a chunk of ROE comes from the balance sheet.
What the company owes vs. what it holds
Year-by-year maturities aren't in SEC companyfacts (footnote-only), so this shows the debt/cash structure and net leverage instead.
Latest year: profit growth vs revenue growth
High operating leverage: profit moved 6.9× as fast as sales — great in an upturn, painful in a downturn.
Each line as % of revenue — the trend in color
| % of revenue | FY2019 | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|---|
| Cost of Revenue | 36.1 | 43.6 | 31.4 | 32.0 | 61.0 | 45.5 | 34.7 |
| Gross Profit | 63.9 | 56.4 | 68.6 | 68.0 | 39.0 | 54.5 | 65.3 |
| R&D | 2.8 | 2.9 | 3.2 | 2.3 | 2.5 | 1.9 | 1.9 |
| SG&A | 16.0 | 25.7 | 37.9 | 29.0 | 33.0 | 37.5 | 39.2 |
| Operating Income | 8.1 | -14.4 | -15.4 | -7.1 | -32.9 | -20.3 | -6.9 |
| Income Tax | -0.8 | -7.8 | -0.7 | 0.3 | -0.4 | -0.1 | 1.2 |
| Net Income | -1.0 | -24.5 | 145.6 | 12.1 | -25.2 | -8.7 | -3.2 |
Green = margin-favorable vs the row's own range · red = unfavorable.
The metrics that matter, over time
A 30-second read on SKIN: price, valuation, headline fundamentals, and an auto-generated scorecard from SEC filings. Flags are rule-based signals, not recommendations.
Ranked against 235 sector peers with collected financials. Valuation from latest close × latest fiscal-year fundamentals; 13F conviction as of 2026-03-31.
Percentile is “goodness” within the peer set (100 = best). For valuation and leverage that means cheaper / less-levered ranks higher.
| Company | Mkt cap ▼ | P/E | EV/EBITDA | P/S | Rev gr | Gross | Net | ROE | ROIC | Net D/EBITDA | 13F |
|---|---|---|---|---|---|---|---|---|---|---|---|
| WMT | $896.8B | 41.1× | — | 1.3× | 4.7% | 24.9% | 3.1% | 22.0% | 15.5% | — | 4,273 |
| COST | $417.5B | 51.7× | 31.9× | 1.5× | 8.2% | 12.8% | 2.9% | 27.8% | 23.2% | 0.4× | 4,050 |
| KO | $373.6B | 28.6× | 24.5× | 7.8× | 1.9% | 61.6% | 27.3% | 40.7% | 40.7% | — | 3,427 |
| PG | $345.0B | 22.6× | 16.3× | 4.1× | 0.3% | 51.2% | 19.0% | 30.6% | 18.4% | 1.5× | 3,849 |
| PM | $294.0B | 26.0× | 17.1× | 7.2× | 7.3% | 67.1% | 27.9% | -114% | -115% | 0.0× | 2,744 |
| PEP | $190.0B | 23.1× | 15.4× | 2.0× | 2.3% | 54.1% | 8.8% | 40.4% | 11.8% | 3.3× | 3,404 |
| BUDFF | $151.5B | — | — | — | — | — | — | — | — | — | 5 |
| UNLYF | $138.7B | — | — | — | — | — | — | — | — | — | 23 |
| MO | $114.6B | 16.6× | 13.2× | 4.9× | -3.1% | 62.5% | 29.8% | -198% | 33.7% | 2.4× | 2,375 |
| MNST | $92.4B | — | 35.6× | 11.1× | 10.7% | 55.8% | 23.0% | 23.1% | 23.1% | — | 1,169 |
| MDLZ | $81.0B | 33.1× | 19.0× | 2.1× | 5.8% | 28.4% | 6.4% | 9.5% | 8.6% | 0.6× | 1,821 |
| CL | $74.7B | 35.5× | 20.4× | 3.7× | 1.4% | 60.1% | 10.5% | 3948% | 30.8% | 1.7× | 1,873 |
| TGT | $66.9B | 18.2× | 9.8× | 0.6× | -1.7% | 27.9% | 3.5% | 22.9% | 12.1% | 1.7× | 1,771 |
| DGEAF | $54.3B | — | — | — | — | — | — | — | — | — | 4 |
| CCEP | $48.8B | — | — | — | — | — | — | — | — | — | 543 |
| ABEV | $47.8B | — | — | — | — | — | — | — | — | — | 383 |
| JBS | $45.1B | — | — | — | — | — | — | — | — | — | 241 |
| FMX | $42.4B | — | — | — | — | — | — | — | — | — | 290 |
| KDP | $41.8B | 20.1× | 14.1× | 2.5× | 8.2% | 54.2% | 12.5% | 8.1% | 5.0% | 4.0× | 784 |
| SYY | $41.1B | 22.6× | 10.3× | 0.5× | 3.2% | 18.4% | 2.2% | 99.9% | 99.9% | — | 1,489 |
| KVUE | $37.7B | 25.9× | 15.7× | 2.5× | -2.1% | 58.1% | 9.7% | 13.7% | 7.1% | 3.4× | 967 |
| ADM | $37.6B | 34.8× | — | 0.5× | -6.2% | 6.3% | 1.3% | 4.7% | 3.6% | — | 1,070 |
| KMB | $37.3B | 18.5× | 11.8× | 2.3× | -2.1% | 36.0% | 12.3% | 135% | 92.0% | 0.2× | 1,585 |
| KR | $37.0B | 36.8× | 9.2× | 0.3× | 0.4% | — | 0.7% | 17.1% | 5.0% | 2.8× | 1,327 |
| HSY | $36.4B | — | 21.2× | 3.1× | 4.4% | 33.5% | 7.6% | 19.0% | 9.3% | 2.5× | 1,406 |
| SKIN | $90M | — | — | 0.3× | -10.0% | 65.3% | -3.2% | -15.6% | -15.6% | — | 114 |
Peers = companies sharing SKIN's sector (Consumer Defensive) with collected SEC financials. Multiples use the most recent end-of-day close and latest fiscal-year fundamentals (trailing, not forward). Missing cells mean the peer never reported that line item, has no collected price, or has a non-positive denominator. Not investment advice.
Top 40 institutional holders — bubble size is position value, color is the move since last quarter. Hover any holder for detail.
Drag any bubble to rearrange · size = dollar value of the position